Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Soucek

Showing results (51-60 of 71) with videos related to

Pageof 8
Sort By:
The EMBO Journal|April 1, 2021
Integrated requirement of non-specific and sequence-specific DNA binding in Myc-driven transcriptionPaola Pellanda, Mattia Dalsass, Marco Filipuzzi, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 11, 2024
EV20/Omomyc: A novel dual MYC/HER3 targeting immunoconjugateSandra Bibbò, Emily Capone, Giulio Lovato, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|September 28, 2019
Targeting Antitumoral Proteins to Breast Cancer by Local Administration of Functional Inclusion BodiesMireia Pesarrodona, Toni Jauset, Zamira V Díaz-Riascos, et al.
Genes & Development|April 6, 2023
Reducing MYC's transcriptional footprint unveils a good prognostic gene signature in melanomaMariano F Zacarías-Fluck, Daniel Massó-Vallés, Fabio Giuntini, et al.
Genes & Development|September 2, 2025
Corrigendum: Reducing MYC's transcriptional footprint unveils a good prognostic gene signature in melanomaMariano F Zacarías-Fluck, Daniel Massó-Vallés, Fabio Giuntini, et al.
Life Science Alliance|March 3, 2021
The Wnt signaling receptor Fzd9 is essential for Myc-driven tumorigenesis in pancreatic isletsMariano F Zacarías-Fluck, Toni Jauset, Sandra Martínez-Martín, et al.
Nature Communications|August 19, 2014
Myc inhibition is effective against glioma and reveals a role for Myc in proficient mitosisDaniela Annibali, Jonathan R Whitfield, Emilia Favuzzi, et al.
Cancer Research|November 8, 2019
Epigenetic <i>SMAD3</i> Repression in Tumor-Associated Fibroblasts Impairs Fibrosis and Response to the Antifibrotic Drug Nintedanib in Lung Squamous Cell CarcinomaRafael Ikemori, Marta Gabasa, Paula Duch, et al.
Nature Medicine|February 6, 2024
MYC targeting by OMO-103 in solid tumors: a phase 1 trialElena Garralda, Marie-Eve Beaulieu, Víctor Moreno, et al.
Nature Communications|November 18, 2024
Generation of chimeric antigen receptor T cells targeting p95HER2 in solid tumorsMacarena Román Alonso, Ariadna Grinyó-Escuer, Santiago Duro-Sánchez, et al.
Pageof 8

Showing results (51-60 of 71) with videos related to

Sort By:
Pageof 8
The EMBO Journal|April 1, 2021
Integrated requirement of non-specific and sequence-specific DNA binding in Myc-driven transcriptionPaola Pellanda, Mattia Dalsass, Marco Filipuzzi, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 11, 2024
EV20/Omomyc: A novel dual MYC/HER3 targeting immunoconjugateSandra Bibbò, Emily Capone, Giulio Lovato, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|September 28, 2019
Targeting Antitumoral Proteins to Breast Cancer by Local Administration of Functional Inclusion BodiesMireia Pesarrodona, Toni Jauset, Zamira V Díaz-Riascos, et al.
Genes & Development|April 6, 2023
Reducing MYC's transcriptional footprint unveils a good prognostic gene signature in melanomaMariano F Zacarías-Fluck, Daniel Massó-Vallés, Fabio Giuntini, et al.
Genes & Development|September 2, 2025
Corrigendum: Reducing MYC's transcriptional footprint unveils a good prognostic gene signature in melanomaMariano F Zacarías-Fluck, Daniel Massó-Vallés, Fabio Giuntini, et al.
Life Science Alliance|March 3, 2021
The Wnt signaling receptor Fzd9 is essential for Myc-driven tumorigenesis in pancreatic isletsMariano F Zacarías-Fluck, Toni Jauset, Sandra Martínez-Martín, et al.
Nature Communications|August 19, 2014
Myc inhibition is effective against glioma and reveals a role for Myc in proficient mitosisDaniela Annibali, Jonathan R Whitfield, Emilia Favuzzi, et al.
Cancer Research|November 8, 2019
Epigenetic <i>SMAD3</i> Repression in Tumor-Associated Fibroblasts Impairs Fibrosis and Response to the Antifibrotic Drug Nintedanib in Lung Squamous Cell CarcinomaRafael Ikemori, Marta Gabasa, Paula Duch, et al.
Nature Medicine|February 6, 2024
MYC targeting by OMO-103 in solid tumors: a phase 1 trialElena Garralda, Marie-Eve Beaulieu, Víctor Moreno, et al.
Nature Communications|November 18, 2024
Generation of chimeric antigen receptor T cells targeting p95HER2 in solid tumorsMacarena Román Alonso, Ariadna Grinyó-Escuer, Santiago Duro-Sánchez, et al.
Pageof 8